ROLE OF THE INTERMEDIATE-CONDUCTANCE Ca2+-ACTIVATED K+ CHANNEL, KCa3.1 SPLICED ISOFORM

被引：0
|
作者：
Ohya, Susumu [1 ]
Niwa, Satomi [1 ]
Yanagi, Ayano [1 ]
Nakamura, Erina [1 ]
Yamamura, Hisao [1 ]
Imaizumi, Yuji [1 ]
机构：
[1] Nagoya City Univ, Dept Mol & Cellular Pharmacol, Nagoya, Aichi, Japan
来源：
JOURNAL OF PHYSIOLOGICAL SCIENCES | 2009年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：255 / 255
页数：1
相关论文
共 50 条
  • [1] Novel spliced variants of the intermediate-conductance Ca2+-activated K+ channel, KCa3.1
    Ohya, Susumu
    Niwa, Satomi
    Yanagi, Ayano
    Nakamura, Erina
    Yamamura, Hisao
    Imaizumi, Yuji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 103P - 103P
  • [2] Dominant-Negative, Spliced Variant of the Intermediate-Conductance Ca2+-Activated K+ Channel, KCa3.1 in Lymphoid Cells
    Ohya, Susumu
    Niwa, Satomi
    Yanagi, Ayano
    Fukuyo, Yuka
    Yamamura, Hisao
    Imaizumi, Yuji
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 691A - 692A
  • [3] Intermediate-conductance Ca2+-activated K+ channel, KCa3.1 as a novel therapeutic target for benign prostatic hyperplasia
    Niwa, Satomi
    Ohya, Susumu
    Kojima, Yoshiyuki
    Sasaki, Shoichi
    Sakuragi, Motomu
    Kohri, Kenjiro
    Imaizumi, Yuji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 94P - 94P
  • [4] Intermediate-Conductance Ca2+-Activated K+ Channel, KCa3.1, as a Novel Therapeutic Target for Benign Prostatic Hyperplasia
    Ohya, Susumu
    Niwa, Satomi
    Kojima, Yoshiyuki
    Sasaki, Shoichi
    Sakuragi, Motomu
    Kohri, Kenjiro
    Imaizumi, Yuji
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (02): : 528 - 536
  • [5] Cancer-Associated Intermediate Conductance Ca2+-Activated K+ Channel KCa3.1
    Mohr, Corinna J.
    Steudel, Friederike A.
    Gross, Dominic
    Ruth, Peter
    Lo, Wing-Yee
    Hoppe, Reiner
    Schroth, Werner
    Brauch, Hiltrud
    Huber, Stephan M.
    Lukowski, Robert
    CANCERS, 2019, 11 (01):
  • [6] The Intermediate-Conductance Ca2+-activated K+ Channel KCa3.1 Regulates Proliferation of Human Coronary Smooth Muscle Cells
    Bi, Dan
    Lemaitre, Vincent
    Takai, Jun
    Miura, Hiroto
    CIRCULATION, 2012, 126 (21)
  • [7] Role of intermediate conductance Ca2+-activated K+ channel, KCa3.1 in cell proliferation in mouse osteoblast cells
    Kito, Hiroaki
    Sakakibara, Yuka
    Morihiro, Haruka
    Ohya, Susumu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S176 - S176
  • [8] The intermediate-conductance Ca2+-activated potassium channel KCa3.1 as novel therapeutic target in malignant melanoma
    Buttstaedt, N.
    Friebel, K.
    Heinemann, S. H.
    Schoenherr, R.
    Adam, C.
    Wulff, H.
    Becker, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (09): : 796 - 796
  • [9] Pharmacological gating modulation of small- and intermediate-conductance Ca2+-activated K+ channels (KCa2.x and KCa3.1)
    Christophersen, Palle
    Wulff, Heike
    CHANNELS, 2015, 9 (06) : 336 - 343
  • [10] A proinvasive role for the Ca2+-activated K+ channel KCa3.1 in malignant glioma
    Turner, Kathryn L.
    Honasoge, Avinash
    Robert, Stephanie M.
    McFerrin, Michael M.
    Sontheimer, Harald
    GLIA, 2014, 62 (06) : 971 - 981
12345